From Name:
From Email:
To Name:
To Email:

Optional Message:


 Hope for powerful new C. difficile treatment

from ScienceDaily

MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly MRSA and Clostridium difficile bugs. The Glasgow-based company is working on a new compound which has proved to be more effective in killing and preventing C diff. than vancomycin, currently one of the most widely used treatments against this bacterium. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063